Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Ketorolac Tromethamine

U.S. FDA Requirements: Ketorolac Tromethamine

Pharmaceutical / Drug Definition : Interferes with prostaglandin biosynthesis by inhibiting cyclooxygenase pathway of arachidonic acid metabolism; also acts as potent inhibitor of platelet aggregation

Registrar Corp assists Ketorolac Tromethamine companies with:

  • FDA Registration Ketorolac Tromethamine
  • FDA Listing Ketorolac Tromethamine
  • FDA Label Requirements and Exceptions Ketorolac Tromethamine
  • FDA Import Information Ketorolac Tromethamine
  • FDA Detentions Ketorolac Tromethamine (Ketorolac Tromethamine Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Ketorolac Tromethamine (Ketorolac Tromethamine Suppliers)
       - Processors Ketorolac Tromethamine
       - Repackers Ketorolac Tromethamine
       - Relabelers Ketorolac Tromethamine
       - Exporters Ketorolac Tromethamine
       - Importers Ketorolac Tromethamine
For more information about Ketorolac Tromethamine, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco